1. Home
  2. AVD vs LCTX Comparison

AVD vs LCTX Comparison

Compare AVD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

N/A

Current Price

$4.08

Market Cap

132.4M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.61

Market Cap

407.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVD
LCTX
Founded
1969
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.4M
407.7M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
AVD
LCTX
Price
$4.08
$1.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$5.00
AVG Volume (30 Days)
221.8K
1.1M
Earning Date
01-01-0001
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$547,306,000.00
$14,556,000.00
Revenue This Year
N/A
$55.75
Revenue Next Year
$3.54
$2.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$3.28
$0.37
52 Week High
$5.92
$2.09

Technical Indicators

Market Signals
Indicator
AVD
LCTX
Relative Strength Index (RSI) 30.62 39.60
Support Level $3.81 $1.55
Resistance Level $4.25 $1.84
Average True Range (ATR) 0.21 0.10
MACD -0.09 -0.04
Stochastic Oscillator 10.23 14.12

Price Performance

Historical Comparison
AVD
LCTX

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: